The effect of oral Eucalyptus on heart rate variability
Phase 2
- Conditions
- Healthy subjects.
- Registration Number
- IRCT2016032911236N6
- Lead Sponsor
- Research and Technology Deputy, Mazandaran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 16
Inclusion Criteria
female; ages between 19-24 years old. Exclusion criteria: chronic disease (i.e. diabetes mellitus, hypertension, epilepsy and etc); smoking; under regular medication
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mean of RR interval. Timepoint: before and after administration of placebo or drug. Method of measurement: Time domain analysis of ECG.;Standard deviation of RR interval. Timepoint: before and after administration of placebo or drug. Method of measurement: Time domain analysis of ECG.
- Secondary Outcome Measures
Name Time Method High frequency power spectrum (a quantity index of cardiac vagal function). Timepoint: before and after administration of placebo or drug. Method of measurement: Frequency domain analysis of ECG.;Low frequency power spectrum. Timepoint: before and after administration of placebo or drug. Method of measurement: Frequency domain analysis of ECG.